HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G’s Moeller Tackles ‘Volatile’ Markets

Executive Summary

Moeller, CFO since 2009, will retain vice chairman and COO posts and continue heading P&G’s enterprise markets, the firm’s smaller markets,

You may also be interested in...



P&G Prepares For Growth To Move From Price Increases To Volume As It Girds For FX Headwind

Contribution of price increases to P&G’s organic sales growth will decrease 3 to 4 points during its FY2024 while volume will “progress sequentially,” says CFO Andre Schulten during firm’s first-quarter earnings briefing. Net sales up 6% to $21.9bn in July-September.

Change At P&G Helm But Not In Course

Speaking at conferences or in P&G’s earnings briefings wasn’t part of previous CEO David Taylor’s strategy. But Jon Moeller has been a mainstay of P&G presentations for years and likely will continue the role.

P&G Begins US Price Increases In Baby And Feminine Care, Could Expand To Health, Beauty

P&G plans up to double-digit price increases in US baby care, feminine care and adult incontinence and will analyze raw material costs and foreign exchange impacts in its other product categories for other pricing changes.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150913

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel